A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China. [electronic resource]
Producer: 20090423Description: 297-303 p. digitalISSN:- 0172-8172
- Administration, Oral
- Adult
- Aged
- Antirheumatic Agents -- administration & dosage
- Arthritis, Rheumatoid -- drug therapy
- China
- Double-Blind Method
- Etanercept
- Female
- Humans
- Immunoglobulin G -- administration & dosage
- Injections, Subcutaneous
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Receptors, Tumor Necrosis Factor -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.